Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink-Reference-Cited by-同舟云学术

Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink

Author:

McGlynn Katherine A.¹,Hagberg Katrina²,Chen Jie¹,Braunlin Megan¹,Graubard Barry I.¹,Suneja Neha²,Jick Susan²,Sahasrabuddhe Vikrant V.³

Affiliation:

1. Division of Cancer Epidemiology and Genetics; National Cancer Institute; Bethesda MD

2. Boston Collaborative Drug Surveillance Program and Boston University School of Public Health; Lexington MA

3. Division of Cancer Prevention; National Cancer Institute; Bethesda MD

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference33 articles.

1. Ferlay J Soerjomatarm I Ervik M et al http://globocan.iarc.fr

2. Promotive effects of ethinyl estradiol in hepatocarcinogenesis initiated by diethylnitrosamine in male rats;Cameron;Gan,1981

3. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats;Yager;Cancer Res,1980

4. Role of estrogens as promoters of hepatic neoplasia;Wanless;Lab Invest,1982

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献